title: Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
authors.forename: K
authors.initials: K
authors.lastname: Kido
authors.forename: K
authors.initials: K
authors.lastname: Mizuta
authors.forename: F
authors.initials: F
authors.lastname: Mizuta
authors.forename: M
authors.initials: M
authors.lastname: Yasuda
authors.forename: T
authors.initials: T
authors.lastname: Igari
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
mesh_terms: D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D003329:Coronary Vasospasm / Q000209:etiology*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000009:adverse effects*; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors; D014062:Tongue Neoplasms / Q000601:surgery; D014673:Vecuronium Bromide / Q000009:adverse effects / Q000037:antagonists & inhibitors
chemical_list: D002800:Cholinesterase Inhibitors; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D014673:Vecuronium Bromide